Revenue | $100 - $500 million See Exact Annual Revenue |
---|---|
Employees | 100 - 500Exact Company Size |
Primary Industry | 325411 Medicinal & Botanical Manufacturing |
Additional NAICS Codes | 31541 32541 |
Address | 500 Technology Square Suite 700 Cambridge, MA 02139 foghorntx.com |
Foghorn Therapeutics | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): |
$ Millions (Industry Average) | |
---|---|
Foghorn Therapeutics Revenue (Sales) | |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
GENE TRAFFIC CONTROL Agents for medical and veterinary use, namely, pharmaceutical preparations for the treatment of diseases and disorders, namely, oncological, neurological, developmental, hematological, bone, respiratory, central nervous system, endrocrinological, metabolic, circulatory, gastroenterological, hormonal and diabetic disorders; pharmaceuticals, namely, epigenetic modulating agents and chromatin regulating agents to treat disease; diagnostic agents, preparations and substances for medical purposes; diagnostic preparation platforms for medicinal use featuring epigenetic modulating agents and chromatin regulating agents to treat disease | 03/19/2018 |
GTC Agents for medical and veterinary use, namely, pharmaceutical preparations for the treatment of diseases and disorders, namely, oncological, neurological, developmental, hematological, bone, respiratory, central nervous system, endrocrinological, metabolic, circulatory, gastroenterological, hormonal and diabetic disorders; pharmaceuticals, namely, epigenetic modulating agents and chromatin regulating agents to treat disease; diagnostic agents, preparations and substances for medical purposes; diagnostic preparation platforms for medicinal use featuring epigenetic modulating agents and chromatin regulating agents to treat disease | 03/19/2018 |
FOGHORN Agents for medical and veterinary use, namely, pharmaceutical preparations for the treatment of diseases and disorders, namely, oncological, neurological, developmental, hematological, bone, respiratory, central nervous system, endrocrinological, metabolic, circulatory, gastroenterological, hormonal and diabetic disorders; pharmaceuticals, namely, epigenetic modulating agents and chromatin regulating agents to treat disease; diagnostic agents, preparations and substances for medical purposes | 11/16/2015 |
Publisher: AnythingResearch
Company | Headquarters | Revenue ($ MM) |
---|---|---|
VITALABS | Mcdonough, GA | 100 |
COUNTRY LANE SALES | Fairview, UT | 81 |
VITA-PURE | Roselle, NJ | 44 |
INPIVOTA | Lindon, UT | 42 |
NEW SPIRIT NATURALS | San Dimas, CA | 24 |
MICROBE FORMULAS | Meridian, ID | 14 |
EXEGI PHARMA | Rockville, MD | 13 |
MEDS & FOOD FOR KIDS | Saint Louis, MO | 9 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
BIOGEN | Cambridge, MA | 100 |
SAREPTA THERAPEUTICS | Cambridge, MA | 36 |
AMYLYX PHARMACEUTICALS | Cambridge, MA | 11 |
BRAINTREE LABORATORIES | Braintree, MA | 8 |
FOGHORN THERAPEUTICS | Cambridge, MA | 5 |
RECRUITMENT STRATEGIES GROUP | Stoneham, MA | 4 |
Company | Revenue ($ MM) |
---|---|
|